Intellia Therapeutics, Inc. (NTLA) — Net Income

Annual figures by fiscal year, from SEC filings.

2015: -$12.40M2016: -$31.63M2017: -$67.54M2018: -$85.34M2019: -$474.19M2020: -$134.23M2021: -$267.89M2022: -$474.19M2023: -$481.19M2024: -$519.02M2025: -$412.69M-$412.69M
2015Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$412.69M+20.5%
2024-$519.02M-7.9%
2023-$481.19M-1.5%
2022-$474.19M-77.0%
2021-$267.89M-99.6%
2020-$134.23M+71.7%
2019-$474.19M-455.6%
2018-$85.34M-26.4%
2017-$67.54M-113.5%
2016-$31.63M-155.2%
2015-$12.40M